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Introduction
Herbal medicines are a mixture of active and
inactive primary and secondary metabolites,
some of which are useful and safe while
others are rather toxic. Components that can
be readily metabolized through existing
biochemical routes in humans may be
regarded as pharmacologically safe. A
combination of these components can
provide synergistic, additive,
complementary and compensated effects
that should be analyzed on human
metabolism to determine the patient specific
pharmacology of herbal medicine. A
comprehensive interaction can be obtained
through the biochemical interactions to
assess their biological efficiency and toxicity
in human. The problems associated with this
kind of interaction analysis are (Klamt et al.,
2007),  herbal medicine include many other
effective compounds (Becker et al., 2007),
there is little information on the drug effect of
each component (Schuster et al., 1999), there
is inconsistent quality of herbal medicines
(due to variability of metabolite
concentrations) (Zhao and Kurata, 2009) and
environmental factors and differences in
processing can effect the metabolite
composition. In this theoretical investigation,
we present some examples of selected exciting
biochemical routes that are transforming how
we can assess the patient specific bioactivity of
herbal medicine and related safety, toxicity
and highlight the side effects. Although the pa
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Abstract
Forecasting what biological effects an active metabolite compartmentalized in a medicinal
plant may have on human health requires intensive research and clinical trials. There are
inconsistencies in the application of herbal medicine in the treatment of disease mostly due
to the metabolic composition. Different herbal strains, growing media and environmental
conditions will alter the metabolite composition of herbal extracts. A modeling approach to
identify the genes, enzymes and signaling pathways involved in the biosynthesis of the
medicinal plant metabolites could harmonize the process of predicting the metabolite
composition. The structural similarity of primary and secondary plant herbal metabolites does
not always provide complete assurance of what pharmacological effect they may have on the
respective human metabolic system. Many of the medicinal plant metabolites are either
unknown or not searchable through current computational resources. In this review, we have
discussed that a system based biological approach comparing human and plant metabolic
signaling networks that could be additionally productive to ascertain the regulatory and
biological processes conferred by a metabolite and their bioactivity pathways in living
systems. A combination of a both systems and structural based approaches can generate new
models that render a better metabolite composition bioactivity reduction, thereby enhancing
the efficacy, safety, and toxicity of herbal medicine processing.
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relationship analysis, there are still
challenges to be met in order to fully
define the safety of herbal medicine.
Due to the complexity of
herbal medicine, the determination of
efficacy remains a significant hurdle in
the field compared to modern drugs.
Despite the lack of robust regulations,
use of herbal medicine has been growing
continuously. Many scientific
approaches have been initiated to
normalize herbal therapies over the
years including structural similarity,
QSAR and SAR. However, studying the
structural similarity of primary and
secondary plant herbal metabolites does
not always give information on what
pharmacological effects they may have
on humans. The metabolic pathways
discovered in plants that overlap with
similar pathways in humans, with
regards to similar energy
consumption/metabolic pathways,
could potentially be used to determine
the efficacy of herbal therapies. This was
assessed in this study through existing
KEGG database and literature
information. Determining the biological
effects of a medicinal plant through
utilization of similar metabolic
pathways could provide the potential
pharmacological efficacy or adverse
effects and thus an integrated biological
approach comparing human and plant
metabolic signaling networks could be
additionally productive to ascertain the
regulatory and biological processes
conferred by the metabolites and their
bioactivity pathways in living systems.
If a new herbal extract has no
information on the entire metabolic
pathways, the essential reactions should
be compared with human metabolic
pathways for the demonstration of
efficacy, safety and toxicity. Further,
herbal extracts have another problem
with inconsistencies of their ingredients
which lead to quality control problems
for the herbal industry in achieving
compliance through the regulatory
guidelines. The elucidation of metabolic
pathways could determine the
involvement of environmental factors
and growing media for herbal medicines
that act to control the production of
beneficial plant metabolites
independent of any seasonal variation.
The understanding of the extracellular
and intracellular parameters could
facilitate the proper time of plant
harvesting to insure a consistent level
and combination of metabolites is
produced for a herbal medicine. The
characterization of plant secondary
metabolic pathways are essential to
assure the safety, quality compliance
and efficacy of herbal products for
contemporary medicinal applications.
Advances in structure activity
relationship
Inexpensive and time effective
computational models together with
compound database for bioactivity
profiling, have revolutionized screening
technology in medicine. The relatively
structural similarity of the known and
unknown components (compounds)
revealed bioactivity of a single
component in the current drug
discovery approach. For the screening of
lead components, fragments and
substituents are aligned with the
scaffold hopes using different
computational languages encoded by
various algorithms to coordinate a
better drug design process. Specialized
herbal medicine formulations can be
screened in combination with various
components to determine the patient
specific bioactivity as being either safe or
toxic. The breadth of the biochemical
interaction of herbal formulation is not
known, in part because of a lack of
available metabolic studies that combine
the various metabolite components. For
example, Orthsosiphone stamineus is a
kind of traditional folk herbal medicine
which contains rosmarininc acid,
sinensetin, euparorin and
tetramethoxyflavonid as principle
marker compounds. The structural
similarity of these components are
identical to human cancer cell chemicals
such as ubiquinol, and upregulation of
these metabolites might provide benefit
through the apoptosis of cancer cells. A
human metabolic database describes
metabolites similar to plants that may be
highly informative to elucidate a
similarity in biochemical pathways for
prospective research validation. Some
proteins are structurally similar between
plants and animals and may have similar
activities, however this is not always
reliable as an example the Arabidopsis
(plant) deetiolated 2 (DET2/DDM1)
gene and human 5α-Reductase are 40%
identical (Li et al., 1996), yet their
bioactivity is quite different. Therefore,
the current drug discovery approaches
cannot be exploited to identify agonistic
and antagonistic effect of the
metabolites. Even the structure based
information is not able to determine the
competitive biological effect of a
metabolite component. A combined
integrated of computational methods,
structure based information and proven
clinical data can help to link the
pharmacological activity to a known
metabolic pathway, but it is almost
impossible to reveal the metabolic effect
for combined components such as in
Orthsosiphone stamineus. Although the
substructure component is recognized
to show similar properties, their
polypharmacological effects in a
combined formulation (herbal
medicine) cannot be revealed by current
drug discovery approaches.
Accelerating determination of
combined components bioactivity
Development of biochemical
interaction database of human and plant
metabolites (components) and
comparative analysis of their interaction
will enable functional profiling of a
combined metabolite component
bioactivity. The required approach aims
to validate and exploit the similarity of
the interaction routes of complex
human and plant metabolic pathways.
Similarity analysis of the biochemical
routes as well as structural identity
determinations of the efficacy, safety,
and toxicity of herbal medicine can
advance herbal medicinal applications
(Agren et al., 2014, Hebar et al., 2013).
Recent examples of similarity in the
interaction routes of human and plant
proteins show some identity for
tyrosine, tryptophan and phenylalanine
biosynthesis (Fig. 1). This similarity
could be used to elucidate the safety or
toxicity of a herbal medicine. The
proteins are useful for both plant and
human metabolic functions by
providing secondary metabolites for
stress protection in plants and
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antioxidants that benefit human health
(Hermann, Janice). For instance,
rosmarinic acid (RA) is widely used
medicinal components found in many
plant species (Shashank and Abhay,
2013). The biosynthetic pathways of RA
in human and plants are nearly identical
and as such can be regarded as safe
component for herbal medicine (Fig. 2).
Many chemical interactions and
alternative biosynthetic pathways are
active during the metabolism of RA,
which are found as sulfoglucuronide
conjugates of RA, methyl RA, 1-O-(2, 4,
5-trimethoxycinnamoyl, caffeic acid
(CAA), ferulic acid (FA) and m-
coumaric acid (COA) (Radutoiu et al.,
2003, Indrasumunar et al., 2009).
A schematic metabolism of RA (Fig. 4),
showed that RA could be converted into
glucuronide conjugate of 1-O-(2, 4, 5-
trimethoxycinnamoyl, flavone, flavonol
and isoflavone into their glucuronide
and/or sulfate conjugates by hydrolytic
cleavage in the digestive tract and these
metabolites are found in the plasma and
urine. The metabolism of RA is initiated
Fig
. 1
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of the RA and make p-dehydroxylation
of CAA. The produced CAA and COA
from RA are then absorbed, conjugated
and methylated in tissues. Such herbal
polyphenols are necessary for human
health, being metabolized in the
intestine, liver and kidneys. The
metabolic route of caffeic acid in the
plant is similar to RA which reveals the
requirement for similar enzymatic
activities and metabolite pathways in
plants and animals (Fig. 2A, 2C). As
such the chemicals involved in RA
metabolism in both humans and plants
are unlikely to be toxic of have
detrimental side effects on human
health. Some chemicals produced by
plants are not in the human body and
therefore considered to be a toxic
metabolite. Plants store these chemicals
in specific organelles, tissues or organs
and in some cases release them when
attacked to detour insect or animal
feeding such as jasmonic acid, salicylic
acid, ethylene, and reactive oxygene
species etc (War et al., 2012). Some of
these toxic chemicals can be beneficial
in the correct dose of application
towards human health problems, but
generally they are difficult to administer
and considered unsafe for human
consumption (Wikipedia,
Chemcompound, Vandenberg et al.,
2012). The most toxic compound
known to man is the naturally-
occurring botulinum, 10 gm equivalent
of which would kill one fourth of the
world’s population. The normal level of
monosodium glutamate can cause
attention deficit hyperactivity disorder
(ADHD) risk and autism symptoms.
Adversely, toxic metabolites can be
produced by humans and excreted
through urine and stool, sometimes
being safe for plants while in other
instances quite toxic for plant health
(Mara and Gee, 2010).
Structural similarity of
human and plant chemical metabolites
cannot provide the same bioactivity to
identify the mechanism for human
safety (Hyun et al., 2015). For example,
plant synthesized genistein was
elegantly demonstrated as an agonist
and antagonist for estrogen receptor
activity (NTP-CERHR, 2006). Similar
structures of phytoestrogen lignans,
isoflavones, and coumestans were found
to be identical to human estrogen.
Chemical information and structural
analysis of this plant chemicals may not
help to elucidate the proper biological
effect with safety or toxicity. The
biological activity of genistein is found
in puberty, proliferation, pro- and anti-
estrogenic, which is dependent on the
applied dose of these chemicals. In
breast cancer patients, genistein was
found to proliferate the cells. Some
chemicals such as daidzein and glycitein
are similar to genistein in structure and
the bioactivity might be similar
according to current drug design theory.
The biochemical routes for genistein in
plants showed similar metabolic
functions to that of humans (Fig. 3A)
(Hughes 1998, Sarkar et al., 2006).
Genistein was found in plant to produce
more rhizobial nodule cells in plant
roots, protecting the plants from stress
and interfering with animal
reproductive function (Hughes 1998).
In humans, the biological form of
genistein is the biologically active
glucoside genistin (bound to sugar
molecule) which at first, needs to be
released from the genistein through the
acid hydrolysis in stomach before it can
act as an antibacterial enzyme in the
intestine (Fig. 3A). The absorption and
metabolic rate of gensitein infer higher
bioavailability than genistin which is
similar to the unconjugated form of
aglycone and conjugated glucoside.
After activation of genistein as
hydroxylated and methylated form, it is
located on the cell surface to modulate
the intercellular activity to affect the
several enzymes of cell growth (Figure
3A) (Sarkar, 2006). Plant (in particular,
legume family) uses genistein to fix the
atmospheric nitrogen to ammonia and
form the nodules (root organ) with the
help of bacteria. In such way, ammonia
converted into glutamine and
asparagine to produce carbohydrate, i.e.
malate for plant energy. This nodulation
process is initiated by the signaling
molecule genistein to activate the
bacterial nod gene which produces Nod
factors (NF) by binding with two
receptor-like kinases, Receptor kinases 1
and 5 (NFR1 and NFR5) at the root
epidermis (Fig. 3B, Fig. 4A, 4B)
(Redmond et al., 1986, Spanik 2000,
Stacey et al., 2006, Dénarié et al., 1996,
Limpens et al., 2003, Madsen et al., 2003,
Indrasumunar et al., 2011). These
factors are required to activate the
potassium ion-channels, nucleoporins,
Nodulation Signalling Pathways 1
(MtNSP1 and MtNSP2), ERF (Ets2
repressor factor) for nodulation
(MtERN) and Nodule Inception
(LjNIN) and thereby expression of
ENOD genes in the epidermis. The
cortical and pericycle cell divisions and
continued mutation occur as a result of
cytokinin signaling. During the plant
mutation, cell proliferation and amino
acid production was severely affected by
the oxygen molecules specially the
nitrogenase enzyme complex. To avoid
this oxidation, oxygen is carried out by
the monomeric leghemoglobin protein
in the plant root, which is similar to
human hemoglobin. In human,
genistein participates in the
antiproliferation activity by
downregulating the protein kinase
VEGF, and other signaling factors NF-
kβ, COX-2, AP-1, HIF-1α, matrix
metalloproteinase, FAK, Bcl-2, and Bcl-
XL (Fig. 3B). In line with this, genistein
metabolic function is related to cell
growth, regulation and nutrient supply
which is found both as pro- and anti-
proliferation in human and normal cell
proliferation in plants. In plants, any
pathogenic invasion causes the plant to
produce phytolexins, which are similar
to genistein and help to kill pathogens.
The signaling mechanism triggered by
genistein in plants is not characterized,
yet it appears to differentiate a balance
between phytohormone action and
cellular homeostasis. Genistein works
with bacteria (rhizobia) to mutate the
plant cell whereas lexins works to
protect them. Similarly, human
physiological and pharmacolgoical
activities are modulated by the different
physical and genetic signals to produce
metabolic enzymes which activate the
genes against particular metabolic
process to provide nutritional benefits.
Aristolochia fangchi, is a
Chinese herb that contains aristolochic
acid and shows severe side effects in the
patients who use it for the weight loss
(Nortier et al., 2000). In patients
suffering from renal failure,
nephropathy, urothelial carcinoma by
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the formation of DNA adducts, herbal
medicines such as those containing
pyrrolizidine alkaloids, cause
hepatotoxicity and bleeding of the
gingko biloba (Stephen, 2008). These
side effects and reactions are the result
of the interactions with the intercellular
enzymes, proteins or genes in the
human cell. Herbal components must
have same kind of metabolic interaction
in the plant involving intercellular or
extracellular factors to avoid any side
effects. An advance level of comparison
of these biochemical interactions may
help to identify a similar kind of
mechanism in humans. Plant metabolic
network maps can focus on the
synthesis and degradation of plant and
human components to elucidate the
biochemical routes and interaction for
bioactivity. The interactions can be
further elucidated by examining the site
of synthesis in the organelle, tissues or
organs in both humans and plants in
order to identify the biological efficacy
of herbal medicine. In systems biology,
SBML coding can be sued to identify the
biochemical routes and interactions
(Klamt et al., 2007, Becker et al., 2007)
thereby interrogating the similarities in
metabolic activity. Flux balance analysis
can be used to estimate the safety or
toxicity of the desired metabolism and
consistency of the metabolic
interactions in the herbal extract. In
addition, a stoichiometric matrix and
elementary modes (EMs) (Schuster et
al., 1999) can also, be used to identify the
combined metabolite effect. The EM
analysis can be used to explore all
possible pathways from primary
metabolites to a herbal secondary
metabolite as well as its degradation
products. Since components of the
herbal extract are degraded in human
and act to inhibit or control enzymes as
well as effect gene expression. A
pathway-based mathematical method
Fig.  2. Metabolic route of rosmarinic acid (RA) in plant (A); metabolic route of tyrosine in plant (B); metabolic route of rosmarinic
acid in human (C); metabolic route of caffeic acid (CA) in plant (D). The similarity of metabolic pathways of RA, CA and tyrosine
in living systems could be utilized to determine the reaction mechanism that reaction similarity is useful to determine the
eventual metabolites in plant and human. The end point of the reaction and similarity of the involved catalysts could confirm
the biological efficacy, and interaction of the metabolites.
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Fig. 3. Metabolic route of gensitein in human (A), and metabolic route of genistein in plant (B). The similarity of genistein
metabolic function confirms the pharmacological efficacy in plant and human and thereby we could endorse that genistein
is useful for human use.
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which integrates the altered enzyme
activity distribution into the metabolic
flux distributions (Zhao and Kurata,
2009, Li et al., 1996) would be useful to
predict how the administration of
multiple herbal components changes
the physical and pharmacological
efficacy of the combined metabolites at
the molecular level.
Tracing similarities between plants
and human
All living substances on earth widely
share the same instruction molecule
living unit deoxyribonucleic acid
(DNA) which forms the chromosome
with similar housekeeping genes
(Arabidopsis-Genome-Initiative) but
significant differences in metabolic
function have been identified between
different species. For example, humans
have roughly 18% identical metabolic
function with plants (koshland-science).
Further, it has been observed that heme
molecules of the blood and the
chlorophyll of plants are similar in their
function in energy metabolism
(supplementary Fig. S3). It is assumed
from the structural similarity between
heme and chlorophyll, that light can
penetrate the plant cell with low energy
whereas much energy light source is
required to pass the blood cell
(Gurwitsch et al.,1923). This biological
difference might be due to the
composition of the organism and their
survival activity. It has been reported in
the literature that about 30% genes are
identical in plants and human. Likewise,
48 to 60% of gene-encoded protein
Fig. 4. Metabolic reactions of gensitein in plant (A) and human (B). The metabolic reaction profiling might determine the drug-
drug interaction which mechanism could make a rational prediction formula.
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eukaryotic genes (Arabidopsis-
Genome-Initiative). In most cases, plant
metabolism and energy pathways are
relevant to yeast and bacterial metabolic
functions and their ancestors.
The noteworthy difference in
metabolic processes occures at the
seperation between plants and animals
1.6 billions of years ago with 30%
genetic overlaps (Arabidopsis-Genome-
Initiative). Thus, plant and human
developed a similar “photometabolic
ability. In addition, Chory and Meng
described the proteins involved in the
process of electron transfer chain as well
as the subunits of ATPase important for
photosynthesis in plants. Importantly,
these proteins are encoded by similar
genes in humans.  They also noted the
critical similarities between the genes
important for mitochondrial and
chloroplast function (Meng Chen,
2000). In humans, pre-photosynthetic
transformation for energy production is
observed, a process termed radiogenic
metabolism (Luckey,1980). In this
process, free radicals are precursors of
photosynthesis and respiration using
the active oxygen. Radiogenic
metabolism is also, similar to all
microbes, plants and human for the
cellular growth and energy. To complete
a sufficient energy cycle, cells need
alternative fuel such as light, glucose and
heat (Vander,1970).
Similarities between
metabolites and their integrated
pathways could reveal the mechanism of
disease and treatment for both of plant
and human. For example, the human
protein HSP is not structurally similar to
the RHD3 plant protein but their
function is similar in neuronal
development (Lee et al., 2008, Hu et al.,
2009). Moreover, HSP protein are
mutated through the atlastin signaling
pathways and which can cause
neurodegenerative disorders such as leg
muscle impairment. From this point of
view, malfunction of RHD3 can cause
problems in membrane tubulation and
vesiculation in plants. Through the
impairment of RHD3, endocytic
internalization is less active in plants
(Zheng et al., 2004). RHD3 is also
required for proper axonal maintenance
and synapse development (Evans et al.,
2006, Zhu et al., 2006, Lee et al., 2009).
In addition, both human and plants
produce the glutamate receptor which
has role in cell development, root
growth, morphogenesis and behavior
(Tapken and Hollmann, 2008, Walch-
Liu et al., 2006, Li et al., 2006). These
functions infers similar mechanism
despite their structure is not similar. The
function of the RHD3 and Atlastin were
predicted using the DALI server tools
(supplementary Fig. S4). Therefore, the
structure similarity is not always useful
to rationalize the efficacy of herbal
therapies.
Novel direction to prepare competitive
standardized herbal therapies
If a new herbal extract has no
information on its effects on any
metabolic pathways, the essential
reactions should be compared with
human metabolic pathways for the
demonstration of efficacy, safety and
toxicity (Table S1, S2). In this analysis,
any human metabolites that would be
found to be structurally similar to any of
the plant component compounds (from
KEGG) could then be linked to the
metabolic pathways to infer the efficacy
potential of the medicinal plant
(explanation in Supporting
Information, Fig . S5). As expected due
to the similarity in structure between the
plant and human metabolites, there is
significant overlap between these lists.
The jaccard similarity scores above 0.50
were considered as significant and only
those human metabolites with a
structural similarity score above a given
threshold. In each of the lists of
structurally similar plant metabolites,
very few pathways are clearly over-
represented. For Genistein,
“map00254”, “map00980” and
“map05204” were found as similar to
human metabolism pathways and that
can be considered as 30% safe for
human. Further, herbal extracts have
another problem due to the
inconsistencies in their ingredients
which leads to regulatory compliance
problems for the herbal industry. The
elucidation of important metabolic
pathways could determine the
involvement of environmental factors
and growing media that could be used to
better control the production of
beneficial plant metabolites
independently of seasonal variations.
The understanding of extracellular and
intracellular parameters could give a
better indication when plants should be
harvested to ensure a consistent level
and combination of metabolites are
produced for an herbal medicine. When
omics data such as transcriptome and
metabolome (i.e. KEGG etc.) are
available, statistical analysis is effective
(Table S2). The similarities between
metabolic reactions can be explored by
the principal component analysis (PCA)
and clustering analyses over a variety of
scales between the plant and human
cells. Most-meaningful or significant
changes of metabolites and critical
metabolites (factors) that affect
physiology can be identified via volcano
plots and the least absolute shrinkage
and selection operator (LASSO) or
elastic net regression analysis (Badsha et
al., 2016).
Conclusion
The parameters that influence
the pharmacological efficacy of
medicinal plants are the focus of active
investigations and are important for
understanding the similarities between
metabolic pathways in order to
determine the efficacy, safety, and
toxicity of herbal medicine. The
characterization of plant secondary
metabolic pathways are essential to
ensure the safety, quality compliance
and efficacy of herbal products for
contemporary medicinal applications.
The study of both the system and
clinical pharmacology aspects of the
mechanisms underlying determination
of the similarities between metabolic
pathways in plants and humans could be
an exciting field of research. Due to their
high level of complexity, the
physiological and pharmacological
significance of these interactions are not
yet fully clarified; however, future work
will undoubtedly shed light on these
important molecular interactions and
their roles in metabolic pathways.
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